Invention Application
![MANUFACTURING PROCESS AND INTERMEDIATES FOR A PYRROLO[2,3-D]PYRIMIDINE COMPOUND AND USE THEREOF](/docs/US/2020-04-23/US20200123159A1/abs.jpg.600x600.jpg)
- Patent Title: MANUFACTURING PROCESS AND INTERMEDIATES FOR A PYRROLO[2,3-D]PYRIMIDINE COMPOUND AND USE THEREOF
-
Application No.: US16502703Application Date: 2019-07-03
-
Publication No.: US20200123159A1Publication Date: 2020-04-23
- Inventor: Kapildev Kashmirilal Arora , Jacob Cole DeForest , Andrew Kevern Hills , Brian Patrick Jones , Kris Nicole Jones , Chad Arthur Lewis , Anil Mahadeo Rane
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Main IPC: C07D487/04
- IPC: C07D487/04 ; C07D249/08
![MANUFACTURING PROCESS AND INTERMEDIATES FOR A PYRROLO[2,3-D]PYRIMIDINE COMPOUND AND USE THEREOF](/abs-image/US/2020/04/23/US20200123159A1/abs.jpg.150x150.jpg)
Abstract:
The present invention relates to a manufacturing process and intermediates for preparing a crystalline or non-crystalline form of N-((1S,3S)-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)cyclobutyl)propane-1-sulfonamide. The present invention also relates to salt forms and pharmaceutical compositions comprising the crystalline form, and to methods for use of the compound prepared from a crystalline form in the treatment of various diseases.
Public/Granted literature
- US10815240B2 Manufacturing process and intermediates for a pyrrolo[2,3-d]pyrimidine compound and use thereof Public/Granted day:2020-10-27
Information query
